Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00767715
What this trial is testing

A Study in the Treatment of Acute Mania

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 11
Testing effectiveness (Phase 2)Ended earlyNCT00279409
What this trial is testing

Treatment of Children With ADHD Who do Not Fully Respond to Stimulants

Who this might be right for
Attention Deficit Hyperactivity Disorder
New York State Psychiatric Institute 10
Not applicableStudy completedNCT00294008
What this trial is testing

Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

Who this might be right for
SchizophreniaTranquilizing AgentsMental Disorders+4 more
Janssen Korea, Ltd., Korea 230
Not applicableStudy completedNCT00224276
What this trial is testing

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

Who this might be right for
SchizophreniaBipolar DisorderDiabetes Mellitus
Yale University 100
Post-approval studies (Phase 4)Study completedNCT00576732
What this trial is testing

The Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

Who this might be right for
Autistic DisorderAutism
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 96
Not applicableStudy completedNCT01214135
What this trial is testing

A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 300
Post-approval studies (Phase 4)Ended earlyNCT01615185
What this trial is testing

A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Kaohsiung Kai-Suan Psychiatric Hospital 96
Not applicableStudy completedNCT00692133
What this trial is testing

Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

Who this might be right for
SchizophreniaBipolar Disorder
AstraZeneca 250
Not applicableStudy completedNCT03130478
What this trial is testing

Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 119
Post-approval studies (Phase 4)Study completedNCT00159133
What this trial is testing

Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia

Who this might be right for
SchizophreniaPsychoses
Heinrich-Heine University, Duesseldorf 71
Large-scale testing (Phase 3)Study completedNCT00086593
What this trial is testing

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

Who this might be right for
Schizophrenia
GlaxoSmithKline 209
Large-scale testing (Phase 3)Study completedNCT01092221
What this trial is testing

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode

Who this might be right for
Mania
Sheba Medical Center 180
Not applicableUnknownNCT03130465
What this trial is testing

Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 636
Testing effectiveness (Phase 2)Study completedNCT01779700
What this trial is testing

Fingolimod in Schizophrenia Patients

Who this might be right for
Schizophrenia
Indiana University 40
Large-scale testing (Phase 3)Study completedNCT00637234
What this trial is testing

Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia

Who this might be right for
Schizophrenia
University of Cologne 54
Large-scale testing (Phase 3)Study completedNCT00249236
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisorderManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291
Not applicableStudy completedNCT02877823
What this trial is testing

Improving Cardiometabolic Health of Youth on Antipsychotic Medication

Who this might be right for
Childhood Obesity
University of Maryland, Baltimore 302
Post-approval studies (Phase 4)UnknownNCT02532491
What this trial is testing

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 200
Testing effectiveness (Phase 2)UnknownNCT01598623
What this trial is testing

Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients

Who this might be right for
Oxytocin + Non Specific CounsellingOxytocin + Social Skills TrainingPlacebo + Non Specific Counselling+1 more
Sheba Medical Center 48
Not applicableStudy completedNCT00543088
What this trial is testing

Effectiveness of Anti-Psychotic in GPs Setting

Who this might be right for
SchizophreniaBipolar Disorder
AstraZeneca 250
Next Page